This is a Validated Antibody Database (VAD) review about rat Egfr, based on 254 published articles (read how Labome selects the articles), using Egfr antibody in all methods. It is aimed to help Labome visitors find the most suited Egfr antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Egfr synonym: ERBB1; ErbB-1; Errp

Knockout validation
Abcam
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 9b
Abcam Egfr antibody (Abcam, ab52894) was used in immunohistochemistry knockout validation on mouse samples (fig 9b). Cell Mol Gastroenterol Hepatol (2019) ncbi
Abcam
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:10,000; fig 4b
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on human samples at 1:10,000 (fig 4b). JCI Insight (2021) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry; mouse; loading ...; fig 7b
Abcam Egfr antibody (Abcam, ab52894) was used in immunohistochemistry on mouse samples (fig 7b). Sci Adv (2021) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 2
Abcam Egfr antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2). BMC Cancer (2020) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:1000; loading ...; fig 4d
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on human samples at 1:1000 (fig 4d). Biosci Rep (2020) ncbi
domestic rabbit monoclonal (E235)
  • immunohistochemistry; rat; loading ...; fig 4h
Abcam Egfr antibody (Abcam, ab32077) was used in immunohistochemistry on rat samples (fig 4h). Cell Commun Signal (2020) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s2c
  • immunocytochemistry; human; 1:200; loading ...; fig 2d
  • western blot; human; 1:1000; loading ...; fig s3
Abcam Egfr antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s2c), in immunocytochemistry on human samples at 1:200 (fig 2d) and in western blot on human samples at 1:1000 (fig s3). Nat Commun (2020) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunocytochemistry; human; 1:100; loading ...; fig 6c
  • western blot; human; 1:500; loading ...; fig 6a
Abcam Egfr antibody (Abcam, ab52894) was used in immunocytochemistry on human samples at 1:100 (fig 6c) and in western blot on human samples at 1:500 (fig 6a). Front Oncol (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3d
Abcam Egfr antibody (Abcam, ab5652) was used in western blot on mouse samples at 1:1000 (fig 3d). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (E235)
  • western blot; mouse; 1:2000; loading ...; fig 3d
Abcam Egfr antibody (Abcam, ab32077) was used in western blot on mouse samples at 1:2000 (fig 3d). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; loading ...; fig 3a
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on human samples (fig 3a). Theranostics (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 9b
Abcam Egfr antibody (Abcam, ab52894) was used in immunohistochemistry knockout validation on mouse samples (fig 9b). Cell Mol Gastroenterol Hepatol (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • mass cytometry; human; loading ...; fig 3a
Abcam Egfr antibody (Abcam, ab52894) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:2000; loading ...; fig s5
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on human samples at 1:2000 (fig s5). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; mouse; fig 7a
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on mouse samples (fig 7a). Int J Biol Sci (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; loading ...; fig 3g
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on human samples (fig 3g). J Mol Med (Berl) (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2e
Abcam Egfr antibody (Abcam, ab5644) was used in western blot on human samples (fig 2e). Exp Mol Med (2018) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
  • western blot; human; loading ...; fig 1c
Abcam Egfr antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples (fig 1a) and in western blot on human samples (fig 1c). Exp Mol Med (2018) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:1000; loading ...; fig 6a
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on human samples at 1:1000 (fig 6a). Cancer Sci (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5e
Abcam Egfr antibody (Abcam, ab5644) was used in western blot on human samples (fig 5e). Cell Res (2018) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunocytochemistry; human; 1:960; loading ...; fig s8
Abcam Egfr antibody (Abcam, ab52894) was used in immunocytochemistry on human samples at 1:960 (fig s8). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam Egfr antibody (Abcam, ab5644) was used in western blot on human samples at 1:1000 (fig 3a). Nat Commun (2017) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; loading ...; fig 2b
Abcam Egfr antibody (Abcam, 1138-1) was used in western blot on human samples (fig 2b). Autophagy (2017) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 4d
In order to improve the therapeutic efficacy of cetuximab for non-small cell lung cancer by co-administrating the tumor-penetrating internalizing RGD peptide, Abcam Egfr antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples (fig 4a) and in western blot on human samples (fig 4d). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:1000; loading ...; fig 8
In order to elucidate the relationship between protease prolyl endopeptidase and neural cell adhesion molecule, Abcam Egfr antibody (Abcam, EP38Y) was used in western blot on human samples at 1:1000 (fig 8). J Cell Sci (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunocytochemistry; mouse; fig s1
  • immunohistochemistry; mouse; fig 1
Abcam Egfr antibody (Abcam, ab52894) was used in immunocytochemistry on mouse samples (fig s1) and in immunohistochemistry on mouse samples (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:1000; loading ...; fig 7c
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on human samples at 1:1000 (fig 7c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; loading ...; fig 5a
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on human samples (fig 5a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3a
In order to present the role of nfatc4 in sox9 gene expression in acinar cell plasticity and pancreatic cancer initiation, Abcam Egfr antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples (fig 3a). Stem Cells Int (2016) ncbi
domestic rabbit monoclonal (E235)
  • western blot; human; fig 5
In order to describe functionally enriched ES cell transgenics, Abcam Egfr antibody (Abcam, ab32077) was used in western blot on human samples (fig 5). Sci Rep (2015) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; fig 3
Abcam Egfr antibody (Abcam, ab52894) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; mouse; fig s8
In order to study induction of sarcomatoid phenotype solely due to ductal activation of oncogenic KRAS, Abcam Egfr antibody (Abcam, ab52894) was used in western blot on mouse samples (fig s8). Sci Rep (2015) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunocytochemistry; mouse; 1:100
  • western blot; mouse; 1:1000
Abcam Egfr antibody (Abcam, ab52894) was used in immunocytochemistry on mouse samples at 1:100 and in western blot on mouse samples at 1:1000. Neuroscience (2015) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; mouse
Abcam Egfr antibody (AbCam, EP38Y) was used in western blot on mouse samples . Oncogene (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry; human
Abcam Egfr antibody (Abcam, ab52894) was used in immunohistochemistry on human samples . EMBO J (2011) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-10)
  • western blot; human; loading ...; fig 6a, 8i
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-373746) was used in western blot on human samples (fig 6a, 8i). J Exp Clin Cancer Res (2021) ncbi
mouse monoclonal (A-10)
  • western blot; human; loading ...; fig 2c, 2d
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-373746) was used in western blot on human samples (fig 2c, 2d). Neoplasia (2021) ncbi
mouse monoclonal (528)
  • western blot; human; 1:2000; loading ...; fig 2a
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-120) was used in western blot on human samples at 1:2000 (fig 2a). Nat Commun (2021) ncbi
mouse monoclonal (A-10)
  • western blot; mouse; 1:1000; loading ...; fig 3c
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-373746) was used in western blot on mouse samples at 1:1000 (fig 3c). J Cancer (2020) ncbi
mouse monoclonal (528)
  • immunohistochemistry; human; loading ...; fig s8f
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-120) was used in immunohistochemistry on human samples (fig s8f). Cell (2020) ncbi
mouse monoclonal (A-10)
  • western blot; human; loading ...; fig 10a
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-373746) was used in western blot on human samples (fig 10a). J Virol (2019) ncbi
mouse monoclonal (A-10)
  • western blot; human; 1:1000; loading ...; fig 5g
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, A-10) was used in western blot on human samples at 1:1000 (fig 5g). Cell Mol Life Sci (2019) ncbi
mouse monoclonal
  • western blot; human; 1:1000; loading ...; fig 5g
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, A-10) was used in western blot on human samples at 1:1000 (fig 5g). Cell Mol Life Sci (2019) ncbi
mouse monoclonal (A-10)
  • immunocytochemistry; human; 1:150; loading ...; fig s4i
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-373746) was used in immunocytochemistry on human samples at 1:150 (fig s4i). Science (2018) ncbi
mouse monoclonal
  • western blot; human; 1:660; loading ...; fig 3a
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, A-10) was used in western blot on human samples at 1:660 (fig 3a). J Med Chem (2017) ncbi
mouse monoclonal (A-10)
  • western blot; human; 1:660; loading ...; fig 3a
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, A-10) was used in western blot on human samples at 1:660 (fig 3a). J Med Chem (2017) ncbi
mouse monoclonal (R-1)
  • flow cytometry; human; loading ...; fig s4b
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-101) was used in flow cytometry on human samples (fig s4b) and in western blot on human samples (fig 5a). MBio (2017) ncbi
mouse monoclonal (A-10)
  • western blot; rat; loading ...; fig 13a
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-373746) was used in western blot on rat samples (fig 13a). Am J Pathol (2017) ncbi
mouse monoclonal (E-8)
  • western blot; human; 1:1000; loading ...; fig 5d
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-374607) was used in western blot on human samples at 1:1000 (fig 5d). Sci Rep (2017) ncbi
mouse monoclonal (A-10)
  • western blot; rat; 1:200; loading ...; fig 5
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-373746) was used in western blot on rat samples at 1:200 (fig 5). J Immunol Res (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 7c
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-377229) was used in western blot on human samples (fig 7c). EMBO J (2017) ncbi
mouse monoclonal (R-1)
  • immunocytochemistry; human; 1:250; loading ...; fig 1a
In order to research the role of the endosomal transcriptional regulator RNF11 in EGFR degradation and transportation, Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-101) was used in immunocytochemistry on human samples at 1:250 (fig 1a). J Cell Biol (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:2000; loading ...; fig s6a
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-377229) was used in western blot on human samples at 1:2000 (fig s6a). Nat Cell Biol (2016) ncbi
mouse monoclonal (A-10)
  • western blot; human; 1:1000; loading ...; fig 4g
In order to demonstrate the bipartite role of Hsp90 in chaperoning CRAF kinase, Santa Cruz Biotechnology Egfr antibody (Santa Cruz, SC373746) was used in western blot on human samples at 1:1000 (fig 4g). J Biol Chem (2016) ncbi
mouse monoclonal (528)
  • flow cytometry; Chinese hamsters; fig 1
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, Sc-120) was used in flow cytometry on Chinese hamsters samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (528)
  • flow cytometry; hamsters; loading ...; fig 1d
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, Sc-120) was used in flow cytometry on hamsters samples (fig 1d). Cell Commun Signal (2016) ncbi
mouse monoclonal (528)
In order to determine control of clathrin coat recruitment to early endosomes for fast endocytic recycling by NECAP2, Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-120) was used . J Cell Sci (2016) ncbi
mouse monoclonal (528)
  • immunocytochemistry; human; 1:100; loading ...; fig 7b
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-120) was used in immunocytochemistry on human samples at 1:100 (fig 7b). Oncotarget (2016) ncbi
mouse monoclonal (R-1)
In order to characterize the interaction with the fusion protein of respiratory syncytial virus strain 2-20 and mediation of infection and mucin expression by EGFR, Santa Cruz Biotechnology Egfr antibody (santa Cruz, sc-101) was used . PLoS Pathog (2016) ncbi
mouse monoclonal (A-10)
  • western blot; human; fig 4
Santa Cruz Biotechnology Egfr antibody (santa Cruz, sc-373746) was used in western blot on human samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (R-1)
  • immunocytochemistry; human; 1:100
In order to study the conversion of phosphatidylinositol 3-phosphate to phosphatidylinositol 4-phosphate at endosomes en route to the plasma membrane, Santa Cruz Biotechnology Egfr antibody (Santa Cruz, R-1) was used in immunocytochemistry on human samples at 1:100. Nature (2016) ncbi
mouse monoclonal (R-1)
  • western blot; human; fig 1
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-101) was used in western blot on human samples (fig 1). BMC Cell Biol (2015) ncbi
mouse monoclonal (A-10)
  • western blot; human; fig 6
In order to study the fusion between lysosomes and amphisomes/MVBs regulated by mahogunin via ubiquitination of TSG101, Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-373746) was used in western blot on human samples (fig 6). Cell Death Dis (2015) ncbi
mouse monoclonal (528)
  • flow cytometry; human; 1:100; fig 3d
In order to characterize enhancement of tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b by H19 non coding RNA-derived miR-675, Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-120) was used in flow cytometry on human samples at 1:100 (fig 3d). Oncotarget (2015) ncbi
mouse monoclonal (R-1)
  • immunocytochemistry; human; fig 3
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-101) was used in immunocytochemistry on human samples (fig 3). Mol Biol Cell (2015) ncbi
mouse monoclonal (528)
  • flow cytometry; mouse; fig 5
Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, SC-120) was used in flow cytometry on mouse samples (fig 5). Analyst (2015) ncbi
mouse monoclonal (A-10)
  • western blot; human; fig 1
Santa Cruz Biotechnology Egfr antibody (Santa cruz, sc-373746) was used in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (528)
  • blocking or activating experiments; human; 1:200
In order to study signaling events downstream to the G-protein-coupled estrogen receptor activated by dehydroepiandrosterone, Santa Cruz Biotechnology Egfr antibody (Santa Cruz Biotechnology, sc-120) was used in blocking or activating experiments on human samples at 1:200. J Biol Chem (2015) ncbi
mouse monoclonal (R-1)
  • immunoprecipitation; human; fig 5
  • immunocytochemistry; human; fig s3
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-101) was used in immunoprecipitation on human samples (fig 5) and in immunocytochemistry on human samples (fig s3). J Cell Sci (2015) ncbi
mouse monoclonal (A-10)
  • immunoprecipitation; human
  • western blot; human
In order to identify LRRK1 as a target for FIH-1 during epithelial migration, Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-373746) was used in immunoprecipitation on human samples and in western blot on human samples . Am J Pathol (2014) ncbi
mouse monoclonal (528)
  • immunoprecipitation; human
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, 528) was used in immunoprecipitation on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (528)
  • western blot; human
Santa Cruz Biotechnology Egfr antibody (Santa Cruz, sc-120) was used in western blot on human samples . Mol Oncol (2015) ncbi
mouse monoclonal (R-1)
  • immunohistochemistry; rat; 1:200
Santa Cruz Biotechnology Egfr antibody (Stemcells Inc, SC101) was used in immunohistochemistry on rat samples at 1:200. Neuroreport (2014) ncbi
Invitrogen
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:1000; fig 6c
Invitrogen Egfr antibody (Thermo Fisher Scientific, PA1-1110) was used in immunocytochemistry on mouse samples at 1:1000 (fig 6c). BMC Biol (2021) ncbi
mouse monoclonal (S.684.2)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s2b
  • immunocytochemistry; human; 1:200; loading ...; fig 2e
Invitrogen Egfr antibody (ThermoFisher, S.684.2) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s2b) and in immunocytochemistry on human samples at 1:200 (fig 2e). Nat Commun (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig e11-7b
Invitrogen Egfr antibody (Thermo Fisher Scientific, 44-788) was used in western blot on human samples (fig e11-7b). Nature (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1 ug/ml; loading ...; fig 1c
Invitrogen Egfr antibody (Thermo Fisher, PA1-1110) was used in western blot on human samples at 1 ug/ml (fig 1c). Proc Natl Acad Sci U S A (2019) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:250; loading ...; fig s4i
Invitrogen Egfr antibody (ThermoFischer Scientific, 36-9700) was used in immunocytochemistry on human samples at 1:250 (fig s4i). Science (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s2a
Invitrogen Egfr antibody (Thermo Fisher, 36-9700) was used in western blot on human samples at 1:1000 (fig s2a). Nat Med (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
In order to discover regions of rare genetic variation that contribute to emphysema with severe airflow obstruction, Invitrogen Egfr antibody (Invitrogen, 44-784G) was used in western blot on human samples (fig 5a). Am J Respir Crit Care Med (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 1c
In order to show the Nogo-B receptor promotes accumulation of prenylated Ras at the plasma membrane, Invitrogen Egfr antibody (Invitrogen, PA1-1110) was used in immunocytochemistry on human samples (fig 1c). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 3
In order to assess the contribution of amphiregulin, epidermal growth factor, heparin-binding epidermal growth factor, and transforming growth factor alpha in the responsiveness of gastric cancer cell lines to cetuximab and trastuzumab, Invitrogen Egfr antibody (Invitrogen, 44788G) was used in western blot on human samples at 1:2000 (fig 3). J Cancer Res Clin Oncol (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 4d
In order to improve the therapeutic efficacy of cetuximab for non-small cell lung cancer by co-administrating the tumor-penetrating internalizing RGD peptide, Invitrogen Egfr antibody (Thermo Fisher, 36-9700) was used in immunohistochemistry - paraffin section on human samples (fig 4a) and in western blot on human samples (fig 4d). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5b
In order to elucidate how JNJ-61186372 attenuates therapeutic resistance in patients with epidermal growth factor receptor mutations, Invitrogen Egfr antibody (Invitrogen, 44-794G) was used in western blot on human samples (fig 5b). MAbs (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Invitrogen Egfr antibody (Invitrogen, 44-788G) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
In order to investigate changes to AURKA signaling after treatment with erlotinib/alisertib combination therapy, Invitrogen Egfr antibody (Invitrogen, 44794G) was used . Front Oncol (2015) ncbi
domestic rabbit polyclonal
In order to study a non-small-cell lung cancer and relevant EGFR mutants in an in vitro model to determine mutation specificity of EGFR tyrosine kinase inhibitors, Invitrogen Egfr antibody (Invitrogen, 44788G) was used . Oncotarget (2015) ncbi
domestic rabbit polyclonal
In order to elucidate the mechanism of intracellular activation of EGFR by fatty acid synthase dependent palmitoylation, Invitrogen Egfr antibody (Invitrogen, 44794G) was used . Oncotarget (2015) ncbi
domestic rabbit polyclonal
In order to characterize two new cell lines with the potential to be used to study portal (myo)fibroblasts, Invitrogen Egfr antibody (Thermo Scientific, PA1-1110) was used . PLoS ONE (2015) ncbi
domestic rabbit polyclonal
In order to show that a new alkyne amino acid can be site-selectively incorporated into mammalian proteins, Invitrogen Egfr antibody (Pierce, PA1-1110) was used . ACS Chem Biol (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D7A5)
  • western blot; rat; fig 6a
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on rat samples (fig 6a). Front Pharmacol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2235) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 4407) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 4404) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2231) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2237) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2220) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4d
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2231) was used in western blot on human samples (fig 4d). BMC Cancer (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4d
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2232) was used in western blot on human samples (fig 4d). BMC Cancer (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 5d). Front Pharmacol (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4c
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2234) was used in western blot on mouse samples at 1:1000 (fig 4c). Commun Biol (2021) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; mouse; 1:1000; loading ...; fig 4c
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2646) was used in western blot on mouse samples at 1:1000 (fig 4c). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology Egfr antibody (Cell Signalin, 3777) was used in western blot on human samples (fig 1c). Cancers (Basel) (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:100; loading ...; fig s6b
Cell Signaling Technology Egfr antibody (Cell Signaling, 2237) was used in western blot on human samples at 1:100 (fig s6b). Nucleic Acids Res (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 6a, 8d
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 6a, 8d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig ev5b
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig ev5b). EMBO Mol Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1l
Cell Signaling Technology Egfr antibody (Cell signalling, 2232L) was used in western blot on human samples at 1:1000 (fig 1l). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; loading ...; fig 2e
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 2e). Cancers (Basel) (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 2a
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2234) was used in western blot on human samples at 1:2000 (fig 2a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig s6a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig s6a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; loading ...; fig s1a
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on mouse samples (fig s1a). Cell (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology Egfr antibody (CST, 2220) was used in western blot on human samples at 1:1000 (fig 6b). Front Cell Dev Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology Egfr antibody (CST, 2234) was used in western blot on human samples at 1:1000 (fig 6b). Front Cell Dev Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology Egfr antibody (CST, 2232) was used in western blot on human samples at 1:1000 (fig 6b). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; loading ...; fig 3a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 3a). Mol Oncol (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 4a). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples (fig 1a). Signal Transduct Target Ther (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2232) was used in western blot on human samples (fig 1a). Signal Transduct Target Ther (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2232) was used in western blot on human samples at 1:1000 (fig 1). Biotechnol Rep (Amst) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2d, 2e, 2f
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2234) was used in western blot on human samples at 1:1000 (fig 2d, 2e, 2f). Biotechnol Rep (Amst) (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • immunocytochemistry; mouse; loading ...; fig 5h
  • western blot; mouse; loading ...; fig 5d
Cell Signaling Technology Egfr antibody (Cell Signaling technology, 3777) was used in immunocytochemistry on mouse samples (fig 5h) and in western blot on mouse samples (fig 5d). Cell Res (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4i
Cell Signaling Technology Egfr antibody (Cell Signaling Technologies, 2234) was used in western blot on human samples at 1:1000 (fig 4i). Nature (2020) ncbi
mouse monoclonal (1H12)
  • immunohistochemistry; human; 1:100; loading ...; fig 2j
Cell Signaling Technology Egfr antibody (CST, 1H12) was used in immunohistochemistry on human samples at 1:100 (fig 2j). Dev Cell (2020) ncbi
mouse monoclonal (1H12)
  • immunohistochemistry; mouse; loading ...; fig 4f
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2236) was used in immunohistochemistry on mouse samples (fig 4f). Mol Cancer Ther (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4c
Cell Signaling Technology Egfr antibody (CST, 2234) was used in western blot on human samples at 1:1000 (fig 4c). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology Egfr antibody (CST, 3777) was used in western blot on human samples (fig 1f). FASEB Bioadv (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig s5b
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig s5b). Theranostics (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s2c
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Egfr antibody (Cell signaling, 3777) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s2c) and in western blot on human samples at 1:1000 (fig 3a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 1s3
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 1s3). elife (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; fig 2d
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples at 1:1000 (fig 2d). Nature (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 2a, 3f, 3k
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 2a, 3f, 3k). elife (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig e2b
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig e2b). Nature (2019) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 1b
Cell Signaling Technology Egfr antibody (Cell Signaling, 2234) was used in western blot on rat samples (fig 1b). Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1e
Cell Signaling Technology Egfr antibody (Cell Signaling, 2235) was used in western blot on human samples (fig s1e). Cell (2019) ncbi
domestic rabbit monoclonal (53A5)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 9a
  • western blot; human; 1:1000; loading ...; fig 1b, 8a, s14a
Cell Signaling Technology Egfr antibody (Cell Signaling, 4407) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 9a) and in western blot on human samples at 1:1000 (fig 1b, 8a, s14a). Nat Commun (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:2000; loading ...; fig 2a
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples at 1:2000 (fig 2a). Mol Med Rep (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; human; 1:800; fig 4d
  • western blot; human; 1:1000; loading ...; fig 2a, 2c, 2i
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 4d) and in western blot on human samples at 1:1000 (fig 2a, 2c, 2i). Cell Metab (2019) ncbi
mouse monoclonal (1H12)
  • western blot; human; 1:1000; loading ...; fig 1c
Cell Signaling Technology Egfr antibody (Cell Signaling, 2236) was used in western blot on human samples at 1:1000 (fig 1c). elife (2019) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology Egfr antibody (CST, 4407S) was used in western blot on human samples at 1:1000 (fig 3c). Science (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 5c). Int J Oncol (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 2f
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777S) was used in western blot on human samples at 1:1000 (fig 2f). elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s2
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples (fig s2). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777S) was used in western blot on human samples (fig 1b). BMC Med Genomics (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s6f
Cell Signaling Technology Egfr antibody (Cell Signaling, 2234) was used in western blot on human samples (fig s6f). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (1H12)
  • western blot; mouse; loading ...; fig 3c
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2236) was used in western blot on mouse samples (fig 3c). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:500; loading ...; fig 5g
  • western blot; rat; 1:500; loading ...; fig 5g
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, D7A5) was used in western blot on human samples at 1:500 (fig 5g) and in western blot on rat samples at 1:500 (fig 5g). Cell Mol Life Sci (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples (fig 1c). elife (2018) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit monoclonal (53A5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s5a
Cell Signaling Technology Egfr antibody (Cell Signaling, 4407) was used in immunohistochemistry - paraffin section on mouse samples (fig s5a). Mol Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 1e
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 1e). Science (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1a
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (fig 1a). Mol Med Rep (2018) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 2e
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 2e). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples (fig 2b). Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 8c
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2232) was used in western blot on human samples at 1:1000 (fig 8c). Sci Transl Med (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 8c
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777T) was used in western blot on human samples at 1:1000 (fig 8c). Sci Transl Med (2017) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human; loading ...; fig 7f
In order to investigate the mechanism of the inductive effect of MLKL in necroptosis, Cell Signaling Technology Egfr antibody (cell signalling, 2646) was used in western blot on human samples (fig 7f). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology Egfr antibody (Cell Signaling, 4407) was used in western blot on human samples (fig 1a). Mol Oncol (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Egfr antibody (Cell Signaling, D7A5) was used in western blot on human samples (fig 1b). Cancer Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232L) was used in western blot on human samples (fig 1b). Cancer Res (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Egfr antibody (Cell Signaling, 53A5) was used in western blot on human samples (fig 1b). Cancer Res (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 2
Cell Signaling Technology Egfr antibody (cell signalling, 4407) was used in western blot on human samples (fig 2). Neoplasia (2017) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; mouse; loading ...; fig 1f
In order to report that the Myomixer-Myomaker interaction regulates myofiber formation during muscle development, Cell Signaling Technology Egfr antibody (Cell Signaling, 2646) was used in western blot on mouse samples (fig 1f). Science (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4g
Cell Signaling Technology Egfr antibody (Cell Signaling, 2231) was used in western blot on human samples at 1:1000 (fig 4g). Physiol Rep (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples (fig 5a). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology Egfr antibody (CST, 2232) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology Egfr antibody (CST, 2234) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
  • western blot; mouse; loading ...; fig 2b
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232S) was used in western blot on human samples (fig 2a) and in western blot on mouse samples (fig 2b). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 2a
  • western blot; mouse; loading ...; fig 2b
Cell Signaling Technology Egfr antibody (Cell Signaling, 4407S) was used in western blot on human samples (fig 2a) and in western blot on mouse samples (fig 2b). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology Egfr antibody (Cell signalling, 3777) was used in western blot on human samples (fig 1f). Cancer Lett (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 4a). Theranostics (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples at 1:1000 (fig 6a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 6a
In order to demonstrate that ADAM12 supports the cancer stem cell phenotype in claudin-low breast cancer cells via modulation of the epidermal growth factor receptor pathway, Cell Signaling Technology Egfr antibody (Cell Signaling, D7A5) was used in western blot on human samples (fig 6a). Mol Cancer (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 4a). Biomed Pharmacother (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 4407) was used in western blot on human samples . FEBS Open Bio (2017) ncbi
mouse monoclonal (1H12)
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology Egfr antibody (Cell signaling, 2236) was used in western blot on human samples (fig 2f). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
Cell Signaling Technology Egfr antibody (New England Biolabs, 2234) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology Egfr antibody (Santa Cruz / Cell Signaling Technology, SC-03 / 2232) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2234) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2235) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1c
Cell Signaling Technology Egfr antibody (Cell Signaling, 2231) was used in western blot on mouse samples (fig 1c). Exp Clin Endocrinol Diabetes (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 1c
In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 6a
In order to examine the role of Breast Cancer Associated gene 2 in EGFR endocytosis and down-regulation and to determine its links with breast cancer outcome, Cell Signaling Technology Egfr antibody (Cell signaling, 3777) was used in western blot on human samples (fig 6a). J Cancer (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3
In order to assess the contribution of amphiregulin, epidermal growth factor, heparin-binding epidermal growth factor, and transforming growth factor alpha in the responsiveness of gastric cancer cell lines to cetuximab and trastuzumab, Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (fig 3). J Cancer Res Clin Oncol (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; loading ...; fig 3
In order to propose that casitas B-cell lymphoma family proteins protect mammary epithelial cells from proteotoxic stress-induced cell death by promoting turnover of active c-Src, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; mouse; loading ...; fig 8b
Cell Signaling Technology Egfr antibody (Cell Signaling, 53A5) was used in western blot on mouse samples (fig 8b). J Biol Chem (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; loading ...; fig 8b
Cell Signaling Technology Egfr antibody (Cell Signaling, D7A5) was used in western blot on mouse samples (fig 8b). J Biol Chem (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig s3
In order to report the effects of NVP-CGM097 on the p53wildtype GOT1 cells, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig s3). Neuroendocrinology (2018) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; fig 3a
Cell Signaling Technology Egfr antibody (Cell Signaling, D63B4) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 3a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
In order to demonstrate that entinostat targets SALL4-positive lung cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 2234) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • immunocytochemistry; human; 1:100; fig s6
In order to develop and characterize a three-dimensional model to study tumor-stroma interactions, Cell Signaling Technology Egfr antibody (Cell signaling, 3777S) was used in immunocytochemistry on human samples at 1:100 (fig s6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:100; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Egfr antibody (Cell Signaling, 2235) was used in western blot on human samples at 1:100 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 7b). Cancer Res (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; Chinese hamsters; fig 2
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on Chinese hamsters samples (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 3C
Cell Signaling Technology Egfr antibody (Cell Signaling, 2234) was used in western blot on human samples at 1:1000 (fig 3C). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 4a). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; tbl s6
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (tbl s6). PLoS Genet (2016) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human; 1:1000; loading ...; fig 3f
In order to determine if the extracellular matrix components of human skin fibroblasts change under non-stretch, static stretch, or cyclic stretch conditions, Cell Signaling Technology Egfr antibody (Cell Signaling, 2646) was used in western blot on human samples at 1:1000 (fig 3f). Exp Ther Med (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry; human; 1:200; loading ...; fig s8c
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in immunohistochemistry on human samples at 1:200 (fig s8c). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 1a). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3d
In order to study how CUB domain-containing protein1 contributes to metastasis and drug resistance, Cell Signaling Technology Egfr antibody (Cell Signaling, 2235) was used in western blot on human samples (fig 3d). Breast Cancer Res (2016) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; loading ...; fig 2a
In order to study how CUB domain-containing protein1 contributes to metastasis and drug resistance, Cell Signaling Technology Egfr antibody (Cell Signaling, 6963) was used in western blot on human samples (fig 2a). Breast Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2232) was used in western blot on human samples (fig 2f). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2236) was used in western blot on human samples (fig 2f). Biochim Biophys Acta (2016) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology Egfr antibody (Cell Signaling, 4407) was used in western blot on human samples at 1:1000 (fig 6a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (fig 6a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; fig 5e
In order to discuss the role of myeloid cells in pancreatic cancer pathogenesis, Cell Signaling Technology Egfr antibody (cell signalling, 3777) was used in western blot on human samples at 1:1000 (fig 5e). Gut (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; fig s2
Cell Signaling Technology Egfr antibody (Cell Signaling, 4407) was used in western blot on human samples at 1:1000 (fig s2). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s2
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (fig s2). Nat Commun (2016) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human; loading ...; fig 1a
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Cell Signaling Technology Egfr antibody (Cell Signaling, 2646) was used in western blot on human samples (fig 1a). J Proteomics (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1a
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 1a). J Proteomics (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
In order to characterize attenuation of endosomal EGFR signaling by cathepsin S as a mechanical rationale for the combination of EGFR tyrosine kinase and cathepsin S inhibitors, Cell Signaling Technology Egfr antibody (Cell Signaling, 2235) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
In order to characterize attenuation of endosomal EGFR signaling by cathepsin S as a mechanical rationale for the combination of EGFR tyrosine kinase and cathepsin S inhibitors, Cell Signaling Technology Egfr antibody (Cell Signaling, 2237) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
In order to characterize attenuation of endosomal EGFR signaling by cathepsin S as a mechanical rationale for the combination of EGFR tyrosine kinase and cathepsin S inhibitors, Cell Signaling Technology Egfr antibody (Cell Signaling, 2234) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5d
Cell Signaling Technology Egfr antibody (cell signalling, 2231) was used in western blot on human samples at 1:1000 (fig 5d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig s4
  • western blot; mouse; 1:500; fig s1
Cell Signaling Technology Egfr antibody (Cell Signaling, 2234) was used in western blot on human samples at 1:500 (fig s4) and in western blot on mouse samples at 1:500 (fig s1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 7e
Cell Signaling Technology Egfr antibody (Cell signalling, D7A5) was used in western blot on human samples (fig 7e). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology Egfr antibody (Cell Signalling, 2234) was used in western blot on human samples (fig 5). Traffic (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples (fig 4f). Mol Cell (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 3
Cell Signaling Technology Egfr antibody (Cell signaling, 2232) was used in western blot on human samples at 1:500 (fig 3). Nat Neurosci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 3
Cell Signaling Technology Egfr antibody (Cell signaling, 2234) was used in western blot on human samples at 1:500 (fig 3). Nat Neurosci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:200; fig 2
In order to analyze the induction of the phosphorylation of EGFR and downregulation of cdc25C and MEK phosphorylation by CD147-targeted siRNA in A375 malignant melanoma cells, Cell Signaling Technology Egfr antibody (Cell signaling, 2234) was used in western blot on human samples at 1:200 (fig 2). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2237P) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 4407S) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2235P) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (C24A5)
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2641S) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2220S) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777P) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 4
Cell Signaling Technology Egfr antibody (Cell Signaling Tech, 3777) was used in western blot on human samples (fig 4). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples at 1:1000 (fig 4b). J Clin Invest (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2232) was used in western blot on human samples at 1:1000 (fig 4b). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; mouse; fig 6
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 1
Cell Signaling Technology Egfr antibody (CST, 3777s) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; fig 1
Cell Signaling Technology Egfr antibody (Cell Signaling, 2236) was used in western blot on human samples (fig 1). Oncogenesis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology Egfr antibody (Cell Signaling Tech, 2220) was used in western blot on human samples (fig 4). Cancer Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
In order to determine facilitation of chemoresistance and cancer proliferation by Haem-dependent dimerization of PGRMC1/Sigma-2 receptor, Cell Signaling Technology Egfr antibody (Cell signaling, 2232S) was used in western blot on human samples (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
In order to determine facilitation of chemoresistance and cancer proliferation by Haem-dependent dimerization of PGRMC1/Sigma-2 receptor, Cell Signaling Technology Egfr antibody (Cell signaling, 2234S) was used in western blot on human samples (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Egfr antibody (Cell Signaling, 3056) was used in western blot on human samples (fig 3d). Oncotarget (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; loading ...; fig 2a
In order to research the role of ezrin in EGFR signaling and Erlotinib sensitivity in non-small cell lung cancer cells, Cell Signaling Technology Egfr antibody (Cell Signaling, 2236) was used in western blot on human samples (fig 2a). Neoplasia (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to discuss the findings of The Reproducibility Project: Cancer Biology, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 8
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples (fig 8). Oncogene (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; fig 1
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2236) was used in western blot on human samples (fig 1). Cell Commun Signal (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig 3h
In order to analyze the suppression of soft tissue sarcoma growth due to epigenetic re-expression of HIF-2 alpha, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 3h). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2234) was used in western blot on human samples (fig 4). J Cell Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2232) was used in western blot on human samples (fig 4). J Cell Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; fig 5
In order to determine the role of Kindlin-2 tp activate integrins by cooperating with talin and induction of cell spreading by directly binding paxillin, Cell Signaling Technology Egfr antibody (Cell Signaling, 2235) was used in western blot on mouse samples at 1:2000 (fig 5). elife (2016) ncbi
domestic rabbit polyclonal
  • flow cytometry; human; 2 ug/ml; fig 1
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2232) was used in flow cytometry on human samples at 2 ug/ml (fig 1). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 2235) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 4407) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 2237) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 4404) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 6963) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 4c
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 4c). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 1
Cell Signaling Technology Egfr antibody (Cell Signaling, 2232) was used in immunocytochemistry on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig st12
Cell Signaling Technology Egfr antibody (Cell Signalling, 3777) was used in western blot on human samples at 1:1000 (fig st12). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • immunocytochemistry; human; loading ...; fig 1-s1c
  • western blot; human; loading ...; fig 1-s2c
Cell Signaling Technology Egfr antibody (Cell signaling, 3777) was used in immunocytochemistry on human samples (fig 1-s1c) and in western blot on human samples (fig 1-s2c). elife (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Egfr antibody (Cell signaling, 2235) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Egfr antibody (Cell signaling, 2236) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Egfr antibody (Cell signaling, 2220) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; fig 2
Cell Signaling Technology Egfr antibody (Cell Signaling, 1H12) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 2
Cell Signaling Technology Egfr antibody (Cell Signaling Tech, 2234) was used in western blot on mouse samples (fig 2). Oncogene (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 6
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 6). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; rat; 1:1000; fig 3
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777p) was used in western blot on rat samples at 1:1000 (fig 3). Evid Based Complement Alternat Med (2015) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; mouse; fig 4
In order to investigate changes to AURKA signaling after treatment with erlotinib/alisertib combination therapy, Cell Signaling Technology Egfr antibody (Cell Signaling, 2646) was used in western blot on mouse samples (fig 4). Front Oncol (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; fig 4
In order to investigate changes to AURKA signaling after treatment with erlotinib/alisertib combination therapy, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples (fig 4). Front Oncol (2015) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology Egfr antibody (Cell Signaling, 2231) was used in western blot on mouse samples at 1:1000 (fig 6). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology Egfr antibody (Cell Signaling, 2238) was used in western blot on mouse samples at 1:1000 (fig 6). Cell Death Differ (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 6). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 6
In order to learn the requirement for embryonic poly(A)-binding protein (EPAB) in female mice to provide granulosa cell EGF signaling and cumulus expansion, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2234s) was used in western blot on mouse samples (fig 6). Endocrinology (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:2000; fig s2b
In order to elucidate how EGFR mutations contribute to glioblastoma development, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777S) was used in western blot on human samples at 1:2000 (fig s2b). Mol Cell (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 1
Cell Signaling Technology Egfr antibody (Cell signaling, D7A5) was used in western blot on human samples (fig 1). Glycobiology (2016) ncbi
domestic rabbit monoclonal (C74B9)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4
  • western blot; human; fig 4
Cell Signaling Technology Egfr antibody (Cell Signaling Tech, C74B9) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4) and in western blot on human samples (fig 4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; fig 3
Cell Signaling Technology Egfr antibody (Cell Signaling, 4407S) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human; 1:2000; loading ...; fig 3
Cell Signaling Technology Egfr antibody (Cell Signaling, 2236) was used in western blot on human samples at 1:2000 (fig 3). PLoS ONE (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology Egfr antibody (Cell signaling, 2232) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology Egfr antibody (Cell signaling, 2231) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (1H12)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 5
Cell Signaling Technology Egfr antibody (Cell signaling, 2236S) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 5). Mol Biol Cell (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to study the role of ADAM17 in cellular senescence and senescence secretome, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . Breast Cancer Res (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:500
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:500. Neuroscience (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 1
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 8543) was used in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
Cell Signaling Technology Egfr antibody (Cell Signaling, 2236) was used in western blot on human samples . J Biomed Sci (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human; 1:1000
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2236) was used in western blot on human samples at 1:1000. Oncol Lett (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; fig 5
Cell Signaling Technology Egfr antibody (Cell Signaling, 4407) was used in western blot on human samples (fig 5). EBioMedicine (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; fig s3
Cell Signaling Technology Egfr antibody (Cell Signaling, 4407L) was used in western blot on human samples (fig s3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; loading ...; fig 1c,2a,2b,2c,
In order to study mechanisms that confer resistance to therapeutic interventions in the insulin-like growth factor receptor pathway, Cell Signaling Technology Egfr antibody (CST, 6963) was used in western blot on human samples (fig 1c,2a,2b,2c,). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 4
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
In order to study signaling events downstream to the G-protein-coupled estrogen receptor activated by dehydroepiandrosterone, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2236) was used in western blot on human samples . J Biol Chem (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to study the effect of using an ADAM17 inhibitory antibody, MEDI3622, in several EGFR-dependent tumor models, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . Mol Cancer Ther (2015) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human
In order to study the effect of using an ADAM17 inhibitory antibody, MEDI3622, in several EGFR-dependent tumor models, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 6963) was used in western blot on human samples . Mol Cancer Ther (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
Cell Signaling Technology Egfr antibody (Cell Signaling, 2236) was used in western blot on human samples . Mol Cell Endocrinol (2015) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 6963) was used in western blot on human samples (fig 2a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; fig 4
In order to determine the contribution of low molecular weight protein tyrosine phosphatase to colorectal cancer, Cell Signaling Technology Egfr antibody (Cell Signaling Tech, 3777) was used in western blot on human samples at 1:1000 (fig 4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . Int J Oncol (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 6
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 6). Cancer Cell (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig 5a
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 5a). Mol Med Rep (2015) ncbi
mouse monoclonal (1H12)
  • immunohistochemistry - paraffin section; human; 1:400
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2236) was used in immunohistochemistry - paraffin section on human samples at 1:400. World J Gastroenterol (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human
In order to study the mechanism for the metastasis of ErbB2-positive breast cancer cells, Cell Signaling Technology Egfr antibody (Cell Signaling, 4407) was used in western blot on human samples . J Biol Chem (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology Egfr antibody (Cell Signaling, 53A5) was used in western blot on human samples (fig 1a). Oncogene (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
In order to study the effects of uPA and EGF in breast adenocarcinoma cell lines, Cell Signaling Technology Egfr antibody (Cell Signalling, 2236) was used in western blot on human samples . Mol Carcinog (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • immunoprecipitation; human
  • immunocytochemistry; human; 1:50
  • western blot; human
Cell Signaling Technology Egfr antibody (Cell Signaling, D7A5) was used in immunoprecipitation on human samples , in immunocytochemistry on human samples at 1:50 and in western blot on human samples . Nature (2015) ncbi
domestic rabbit polyclonal
  • western blot; human
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2234) was used in western blot on human samples . J Diabetes (2016) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2646) was used in western blot on human samples . J Diabetes (2016) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; hamsters; loading ...; fig 7a
Cell Signaling Technology Egfr antibody (Cell Signaling, 2646) was used in western blot on hamsters samples (fig 7a). J Biol Chem (2015) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2232S) was used in western blot on rat samples at 1:1000. Mol Neurobiol (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; rat; 1:1000
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777S) was used in western blot on rat samples at 1:1000. Mol Neurobiol (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; rat; 1:500; fig 10
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on rat samples at 1:500 (fig 10). J Appl Toxicol (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig s1
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples (fig s1). Oncogene (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse
In order to determine the effect of STA-2842 on liver size and cystic burden in Pkd-/- mice with established polycystic liver disease, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777S) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; mouse
In order to determine the effect of STA-2842 on liver size and cystic burden in Pkd-/- mice with established polycystic liver disease, Cell Signaling Technology Egfr antibody (Cell Signaling, 2646) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to identify mechanisms by which metastatic gastroesophageal adenocarcinomas develop resistance to ERBB2 inhibition, Cell Signaling Technology Egfr antibody (Cell Signaling Technologies, 3777) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (1H12)
  • western blot; human; fig 4
Cell Signaling Technology Egfr antibody (Cell Signaling, 2236S) was used in western blot on human samples (fig 4). Proc Natl Acad Sci U S A (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; fig 4B
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 4B). Environ Health Perspect (2015) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human
In order to determine if inhibition of AKT signaling augments erlotinib activity and abrogates HGF-mediated resistance, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2646) was used in western blot on human samples . J Cancer Res Clin Oncol (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
Cell Signaling Technology Egfr antibody (Cell Signaling, 2236) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (1H12)
  • western blot; human
In order to study the effect of Hinokitiol on DNA damage and autophagy in gefitinib-resistant lung adenocarcinoma cells, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2236S) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . Biochim Biophys Acta (2014) ncbi
mouse monoclonal (1H12)
  • western blot; human
In order to study mechanism of resistance to the FGFR inhibitor BGJ398 and the FGFR inhibitor ponatinib, Cell Signaling Technology Egfr antibody (cell signaling, 2236S) was used in western blot on human samples . Oncogene (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777S) was used in western blot on human samples at 1:1000. Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human; fig 1c
In order to suggest that Akt activation by ERBB3/HER2 limits the effectiveness of EGFR inhibition, Cell Signaling Technology Egfr antibody (Cell Signaling Technology, 2646) was used in western blot on human samples (fig 1c). Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; human; 1:400
  • western blot; human; 1:1000
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in immunohistochemistry - paraffin section on human samples at 1:400 and in western blot on human samples at 1:1000. Mol Oncol (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - free floating section; chicken
Cell Signaling Technology Egfr antibody (Cell Signaling Technology, CST-3777) was used in immunohistochemistry - free floating section on chicken samples . Oncogene (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to study targeting sEcad for treatment of breast cancer, Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in western blot on human samples . Mol Carcinog (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - frozen section; mouse
  • immunohistochemistry - paraffin section; human
Cell Signaling Technology Egfr antibody (Cell Signaling, 3777) was used in immunohistochemistry - frozen section on mouse samples and in immunohistochemistry - paraffin section on human samples . PLoS ONE (2013) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000
Cell Signaling Technology Egfr antibody (Cell signal, 3777) was used in western blot on human samples at 1:1000. Cell Tissue Res (2013) ncbi
domestic rabbit monoclonal (C74B9)
  • immunocytochemistry; human; fig 3a
Cell Signaling Technology Egfr antibody (Cell Signaling, C74B9) was used in immunocytochemistry on human samples (fig 3a). Sci Signal (2012) ncbi
Biotrend
  • immunohistochemistry - frozen section; rat; 1:200
  • immunocytochemistry; rat; 1:250
Biotrend Egfr antibody (Biotrend, BT 17-2090-07) was used in immunohistochemistry - frozen section on rat samples at 1:200 and in immunocytochemistry on rat samples at 1:250. J Comp Neurol (2008) ncbi
BD Biosciences
mouse monoclonal (21/Mena)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
BD Biosciences Egfr antibody (BD Bioscience, 610693) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Oncoimmunology (2016) ncbi
mouse monoclonal (21/Mena)
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 1
In order to characterize a quantitative method of metastasis assessment called Menacalc that is a prognostic marker for axillary node-negative breast cancer, BD Biosciences Egfr antibody (BD Biosciences, 610693) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 1). BMC Cancer (2015) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7f
MilliporeSigma Egfr antibody (Atlas Antibodies, HPA018530) was used in western blot on human samples (fig 7f). elife (2020) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:100; loading ...; fig 3e
  • western blot; human; 1:1000; loading ...; fig 1d
In order to examine the role of Breast Cancer Associated gene 2 in EGFR endocytosis and down-regulation and to determine its links with breast cancer outcome, MilliporeSigma Egfr antibody (Sigma, HPA018530) was used in immunocytochemistry on human samples at 1:100 (fig 3e) and in western blot on human samples at 1:1000 (fig 1d). J Cancer (2016) ncbi
Articles Reviewed
  1. Shi Y, Hu Y, Wang Y, Ma X, Tang L, Tao M, et al. Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis. Front Pharmacol. 2021;12:724141 pubmed publisher
  2. Lo Cascio C, McNamara J, Melendez E, Lewis E, Dufault M, Sanai N, et al. Nonredundant, isoform-specific roles of HDAC1 in glioma stem cells. JCI Insight. 2021;6: pubmed publisher
  3. Wang Y, Liu I, Chen K, Wu H. NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck. Oncogenesis. 2021;10:59 pubmed publisher
  4. Moon S, Lee H, Kim S, Hong J, Chun S, Lee H, et al. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells. BMC Cancer. 2021;21:931 pubmed publisher
  5. Wang Y, Liu X, Hu G, Hu C, Gao Y, Huo M, et al. EGFR-IL-6 Signaling Axis Mediated the Inhibitory Effect of Methylseleninic Acid on Esophageal Squamous Cell Carcinoma. Front Pharmacol. 2021;12:719785 pubmed publisher
  6. Coudert L, Osseni A, Gangloff Y, Schaeffer L, Leblanc P. The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways. BMC Biol. 2021;19:153 pubmed publisher
  7. Shang P, Stepicheva N, Teel K, McCauley A, Fitting C, Hose S, et al. βA3/A1-crystallin regulates apical polarity and EGFR endocytosis in retinal pigmented epithelial cells. Commun Biol. 2021;4:850 pubmed publisher
  8. Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
  9. Wang Q, Tao C, Hannan A, Yoon S, Min X, Peregrin J, et al. Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling. Sci Adv. 2021;7: pubmed publisher
  10. Torres A, Rodríguez Escribà M, Marcet Houben M, Santos Vieira H, Camacho N, Catena H, et al. Human tRNAs with inosine 34 are essential to efficiently translate eukarya-specific low-complexity proteins. Nucleic Acids Res. 2021;49:7011-7034 pubmed publisher
  11. Zhu J, Cai T, Zhou J, Du W, Zeng Y, Liu T, et al. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer. J Exp Clin Cancer Res. 2021;40:192 pubmed publisher
  12. Xu H, Yang X, Xuan X, Wu D, Zhang J, Xu X, et al. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway. Neoplasia. 2021;23:607-623 pubmed publisher
  13. Citron F, Segatto I, Musco L, Pellarin I, Rampioni Vinciguerra G, Franchin G, et al. miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC. EMBO Mol Med. 2021;13:e12872 pubmed publisher
  14. Tripathi P, Guo H, Dreser A, Yamoah A, Sechi A, Jesse C, et al. Pathomechanisms of ALS8: altered autophagy and defective RNA binding protein (RBP) homeostasis due to the VAPB P56S mutation. Cell Death Dis. 2021;12:466 pubmed publisher
  15. Catalano A, Adlesic M, Kaltenbacher T, Klar R, Albers J, Seidel P, et al. Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers (Basel). 2021;13: pubmed publisher
  16. Wang Z, Goto Y, Allevato M, Wu V, Saddawi Konefka R, Gilardi M, et al. Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. Nat Commun. 2021;12:2383 pubmed publisher
  17. Wang X, Zhang H, Sapio R, Yang J, Wong J, Zhang X, et al. SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer. Nat Commun. 2021;12:2259 pubmed publisher
  18. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  19. Gao S, Gao L, Wang S, Shi X, Yue C, Wei S, et al. ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway. Front Cell Dev Biol. 2021;9:618987 pubmed publisher
  20. Hoesl C, Frohlich T, Posch C, Kneitz H, Goebeler M, Schneider M, et al. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis. Mol Oncol. 2021;15:2140-2155 pubmed publisher
  21. Kitazawa K, Nadanaka S, Kadomatsu K, Kitagawa H. Chondroitin 6-sulfate represses keratinocyte proliferation in mouse skin, which is associated with psoriasis. Commun Biol. 2021;4:114 pubmed publisher
  22. Ni W, Chen Z, Zhou X, Yang R, Yu M, Lu J, et al. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma. Signal Transduct Target Ther. 2021;6:27 pubmed publisher
  23. Wang Q, Gavin W, Masiello N, Tran K, Laible G, Shepherd P. Cetuximab produced from a goat mammary gland expression system is equally efficacious as innovator cetuximab in animal cancer models. Biotechnol Rep (Amst). 2020;28:e00533 pubmed publisher
  24. Zhou S, Zhang W, Cai G, Ding Y, Wei C, Li S, et al. Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration. Cell Res. 2020;30:1063-1077 pubmed publisher
  25. Banik S, Pedram K, Wisnovsky S, Ahn G, Riley N, Bertozzi C. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature. 2020;584:291-297 pubmed publisher
  26. Dabelsteen S, Pallesen E, Marinova I, Nielsen M, Adamopoulou M, Rømer T, et al. Essential Functions of Glycans in Human Epithelia Dissected by a CRISPR-Cas9-Engineered Human Organotypic Skin Model. Dev Cell. 2020;54:669-684.e7 pubmed publisher
  27. Du Z, Dong J, Li M, Zhang J, Bi J, Ren Y, et al. Overexpression of Platelet-Derived Growth Factor Receptor Α D842V Mutants Prevents Liver Regeneration and Chemically Induced Hepatocarcinogenesis via Inhibition of MET and EGFR. J Cancer. 2020;11:4614-4624 pubmed publisher
  28. Izumi H, Wang Z, Goto Y, Ando T, Wu X, Zhang X, et al. Pathway-Specific Genome Editing of PI3K/mTOR Tumor Suppressor Genes Reveals that PTEN Loss Contributes to Cetuximab Resistance in Head and Neck Cancer. Mol Cancer Ther. 2020;19:1562-1571 pubmed publisher
  29. Mahameed M, Boukeileh S, Obiedat A, Darawshi O, Dipta P, Rimon A, et al. Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy. Nat Commun. 2020;11:1304 pubmed publisher
  30. Chew H, De Lima P, Gonzalez Cruz J, Banushi B, Echejoh G, Hu L, et al. Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies. Cell. 2020;180:895-914.e27 pubmed publisher
  31. Howell M, Green R, Khalil R, Foran E, Quarni W, Nair R, et al. Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis. FASEB Bioadv. 2020;2:90-105 pubmed publisher
  32. Padthaisong S, Thanee M, Namwat N, Phetcharaburanin J, Klanrit P, Khuntikeo N, et al. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. BMC Cancer. 2020;20:154 pubmed publisher
  33. Hu D, Chen H, Lou L, Zhang H, Yang G. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis. Biosci Rep. 2020;40: pubmed publisher
  34. Haag A, Walser M, Henggeler A, Hajnal A. The CHORD protein CHP-1 regulates EGF receptor trafficking and signaling in C. elegans and in human cells. elife. 2020;9: pubmed publisher
  35. Ayanlaja A, Ji G, Wang J, Gao Y, Cheng B, Kanwore K, et al. Doublecortin undergo nucleocytoplasmic transport via the RanGTPase signaling to promote glioma progression. Cell Commun Signal. 2020;18:24 pubmed publisher
  36. Chen X, Wang K, Guo W, Li L, Yu P, Sun X, et al. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics. 2020;10:1833-1848 pubmed publisher
  37. Meng X, Zhao Y, Han B, Zha C, Zhang Y, Li Z, et al. Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways. Nat Commun. 2020;11:594 pubmed publisher
  38. Zhao J, Li X, Liu L, Cao J, Goscinski M, Fan H, et al. Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer. Front Oncol. 2019;9:1494 pubmed publisher
  39. Lyashenko E, Niepel M, Dixit P, Lim S, Sorger P, Vitkup D. Receptor-based mechanism of relative sensing and cell memory in mammalian signaling networks. elife. 2020;9: pubmed publisher
  40. Xue J, Zhao Y, Aronowitz J, Mai T, Vides A, Qeriqi B, et al. Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition. Nature. 2020;577:421-425 pubmed publisher
  41. Zeng H, Castillo Cabrera J, Manser M, Lu B, Yang Z, Strande V, et al. Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. elife. 2019;8: pubmed publisher
  42. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed publisher
  43. Lundby A, Franciosa G, Emdal K, Refsgaard J, Gnosa S, Bekker Jensen D, et al. Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites. Cell. 2019;179:543-560.e26 pubmed publisher
  44. Wang C, Vegna S, Jin H, Benedict B, Lieftink C, Ramirez C, et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature. 2019;: pubmed publisher
  45. Sang Y, Li Y, Zhang Y, Alvarez A, Yu B, Zhang W, et al. CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity. Nat Commun. 2019;10:4013 pubmed publisher
  46. Wang K, Zhu T, Zhao R. Filamin A regulates EGFR/ERK/Akt signaling and affects colorectal cancer cell growth and migration. Mol Med Rep. 2019;20:3671-3678 pubmed publisher
  47. Nagpal A, Redvers R, Ling X, Ayton S, Fuentes M, Tavancheh E, et al. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis. Breast Cancer Res. 2019;21:94 pubmed publisher
  48. Bi J, Ichu T, Zanca C, Yang H, Zhang W, Gu Y, et al. Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling. Cell Metab. 2019;30:525-538.e8 pubmed publisher
  49. Du F, Qiao C, Li X, Chen Z, Liu H, Wu S, et al. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR. Theranostics. 2019;9:3879-3902 pubmed publisher
  50. Wen H, Gao S, Wang Y, Ray M, Magnuson M, Wright C, et al. Myeloid cell-derived HB-EGF Drives Tissue Recovery After Pancreatitis. Cell Mol Gastroenterol Hepatol. 2019;: pubmed publisher
  51. Larsen M, Pérez Verdaguer M, Schmidt B, Bruchez M, Watkins S, Sorkin A. Generation of endogenous pH-sensitive EGF receptor and its application in high-throughput screening for proteins involved in clathrin-mediated endocytosis. elife. 2019;8: pubmed publisher
  52. Chung H, Zou X, Bajar B, Brand V, Huo Y, Alcudia J, et al. A compact synthetic pathway rewires cancer signaling to therapeutic effector release. Science. 2019;364: pubmed publisher
  53. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  54. Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R, et al. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway. Int J Oncol. 2019;54:1466-1480 pubmed publisher
  55. Fearnley G, Young K, Edgar J, Antrobus R, Hay I, Liang W, et al. The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion. elife. 2019;8: pubmed publisher
  56. Drews K, Calgi M, Harrison W, Drews C, Costa Pinheiro P, Shaw J, et al. Glucosylceramidase Maintains Influenza Virus Infection by Regulating Endocytosis. J Virol. 2019;93: pubmed publisher
  57. Quinney K, Frankel E, Shankar R, Kasberg W, Luong P, Audhya A. Growth factor stimulation promotes multivesicular endosome biogenesis by prolonging recruitment of the late-acting ESCRT machinery. Proc Natl Acad Sci U S A. 2019;116:6858-6867 pubmed publisher
  58. Pergu R, Dagar S, Kumar H, Kumar R, Bhattacharya J, Mylavarapu S. The chaperone ERp29 is required for tunneling nanotube formation by stabilizing MSec. J Biol Chem. 2019;294:7177-7193 pubmed publisher
  59. Greer Y, Gilbert S, Gril B, Narwal R, Peacock Brooks D, Tice D, et al. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. Breast Cancer Res. 2019;21:27 pubmed publisher
  60. Liu J, Zhu G, Jia N, Wang W, Wang Y, Yin M, et al. CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17. Int J Biol Sci. 2019;15:493-506 pubmed publisher
  61. Nava M, Dutta P, Zemke N, Farias Eisner R, Vadgama J, Wu Y. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets. BMC Med Genomics. 2019;12:32 pubmed publisher
  62. Kubli S, Bassi C, Roux C, Wakeham A, Göbl C, Zhou W, et al. AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer. Proc Natl Acad Sci U S A. 2019;116:3604-3613 pubmed publisher
  63. Xie C, Zhu J, Wang X, Chen J, Geng S, Wu J, et al. Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway. J Exp Clin Cancer Res. 2019;38:39 pubmed publisher
  64. Wintgens J, Wichert S, Popovic L, Rossner M, Wehr M. Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays. Cell Mol Life Sci. 2019;76:1185-1199 pubmed publisher
  65. Tang Z, Ding Y, Shen Q, Zhang C, Li J, Nazar M, et al. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT. J Mol Med (Berl). 2019;97:127-140 pubmed publisher
  66. Unni A, Harbourne B, Oh M, Wild S, Ferrarone J, Lockwood W, et al. Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells. elife. 2018;7: pubmed publisher
  67. Lee S, Cho Y, Cha P, Yoon J, Ro E, Jeong W, et al. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab. Exp Mol Med. 2018;50:153 pubmed publisher
  68. Liang C, Ma Y, Yong L, Yang C, Wang P, Liu X, et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma. Cancer Sci. 2019;110:166-179 pubmed publisher
  69. Gut G, Herrmann M, Pelkmans L. Multiplexed protein maps link subcellular organization to cellular states. Science. 2018;361: pubmed publisher
  70. Fan P, Narzisi G, Jayaprakash A, Venturini E, Robine N, Smibert P, et al. YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proc Natl Acad Sci U S A. 2018;115:E6030-E6038 pubmed publisher
  71. Xue Z, Vis D, Bruna A, Sustic T, van Wageningen S, Batra A, et al. MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models. Cell Res. 2018;28:719-729 pubmed publisher
  72. Park J, Kim I, Choi J, Lim H, Shin J, Kim Y, et al. AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development. Mol Cancer Res. 2018;16:1287-1298 pubmed publisher
  73. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  74. Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359:920-926 pubmed publisher
  75. Park G, Kim D. Cigarette smoke-induced EGFR activation promotes epithelial mesenchymal migration of human retinal pigment epithelial cells through regulation of the FAK-mediated Syk/Src pathway. Mol Med Rep. 2018;17:3563-3574 pubmed publisher
  76. Oldrini B, Hsieh W, Erdjument Bromage H, Codega P, Carro M, Curiel García A, et al. EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer. Nat Commun. 2017;8:2035 pubmed publisher
  77. Yu R, Longo J, van Leeuwen J, Mullen P, Ba Alawi W, Haibe Kains B, et al. Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins. Cancer Res. 2018;78:1347-1357 pubmed publisher
  78. Zeng L, Kang R, Zhu S, Wang X, Cao L, Wang H, et al. ALK is a therapeutic target for lethal sepsis. Sci Transl Med. 2017;9: pubmed publisher
  79. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher
  80. Liu S, Liu H, Johnston A, Hanna Addams S, Reynoso E, Xiang Y, et al. MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis. Proc Natl Acad Sci U S A. 2017;114:E7450-E7459 pubmed publisher
  81. Baumann C, Ullrich A, Torka R. GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance. Mol Oncol. 2017;11:1430-1447 pubmed publisher
  82. Laviolette L, Mermoud J, Calvo I, Olson N, Boukhali M, Steinlein O, et al. Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein. Nat Commun. 2017;8:15866 pubmed publisher
  83. ElHady A, Abdel Halim M, Abadi A, Engel M. Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins. J Med Chem. 2017;60:5377-5391 pubmed publisher
  84. Vaishnavi A, Schubert L, Rix U, Marek L, Le A, Keysar S, et al. EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases. Cancer Res. 2017;77:3551-3563 pubmed publisher
  85. Xiao Z, Gaertner S, Morresi Hauf A, Genzel R, Duell T, Ullrich A, et al. Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients. Neoplasia. 2017;19:385-395 pubmed publisher
  86. Bi P, Ramirez Martinez A, Li H, Cannavino J, McAnally J, Shelton J, et al. Control of muscle formation by the fusogenic micropeptide myomixer. Science. 2017;356:323-327 pubmed publisher
  87. Setty B, Pillay Smiley N, Pool C, Jin Y, Liu Y, Nelin L. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017;5: pubmed publisher
  88. Solis N, Swidergall M, Bruno V, Gaffen S, Filler S. The Aryl Hydrocarbon Receptor Governs Epithelial Cell Invasion during Oropharyngeal Candidiasis. MBio. 2017;8: pubmed publisher
  89. Lee H, Kim M, Baek M, Morales L, Jang I, Slaga T, et al. Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development. Sci Rep. 2017;7:45077 pubmed publisher
  90. Manzanares M, Usui A, Campbell D, Dumur C, Maldonado G, Fausther M, et al. Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model. Am J Pathol. 2017;187:1068-1092 pubmed publisher
  91. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  92. Shizu R, Osabe M, Perera L, Moore R, Sueyoshi T, Negishi M. Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation. Mol Cell Biol. 2017;37: pubmed publisher
  93. Li K, Mo C, Gong D, Chen Y, Huang Z, Li Y, et al. DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin. Cancer Lett. 2017;400:194-202 pubmed publisher
  94. Shi J, Bei Y, Kong X, Liu X, Lei Z, Xu T, et al. miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury. Theranostics. 2017;7:664-676 pubmed publisher
  95. Peiris D, Spector A, Lomax Browne H, Azimi T, Ramesh B, Loizidou M, et al. Cellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factors. Sci Rep. 2017;7:43006 pubmed publisher
  96. Radder J, Zhang Y, Gregory A, Yu S, Kelly N, Leader J, et al. Extreme Trait Whole-Genome Sequencing Identifies PTPRO as a Novel Candidate Gene in Emphysema with Severe Airflow Obstruction. Am J Respir Crit Care Med. 2017;196:159-171 pubmed publisher
  97. Dong Q, Fu L, Zhao Y, Tan S, Wang E. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling. Oncotarget. 2017;8:17059-17069 pubmed publisher
  98. Duhachek Muggy S, Qi Y, Wise R, Alyahya L, Li H, Hodge J, et al. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer. Mol Cancer. 2017;16:32 pubmed publisher
  99. Melchionna R, Iapicca P, Di Modugno F, Trono P, Sperduti I, Fassan M, et al. The pattern of hMENA isoforms is regulated by TGF-?1 in pancreatic cancer and may predict patient outcome. Oncoimmunology. 2016;5:e1221556 pubmed publisher
  100. Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, et al. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Biomed Pharmacother. 2017;88:421-429 pubmed publisher
  101. Ma K, Fu W, Tang M, Zhang C, Hou T, Li R, et al. PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment. Autophagy. 2017;13:579-591 pubmed publisher
  102. Cao H, Yu S, Chen D, Jing C, Wang Z, Ma R, et al. Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR-TKI treatment. FEBS Open Bio. 2017;7:35-43 pubmed publisher
  103. Zhao B, Hu W, Kumar S, Gonyo P, Rana U, Liu Z, et al. The Nogo-B receptor promotes Ras plasma membrane localization and activation. Oncogene. 2017;36:3406-3416 pubmed publisher
  104. Li J, Liu B, Shi Y, Xie K, Yin H, Yan L, et al. CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction. J Immunol Res. 2016;2016:9276986 pubmed publisher
  105. Kozlova N, Wottawa M, Katschinski D, Kristiansen G, Kietzmann T. Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer. Oncotarget. 2017;8:9885-9898 pubmed publisher
  106. Khelwatty S, Essapen S, Bagwan I, Green M, Seddon A, Modjtahedi H. The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer. Oncotarget. 2017;8:7666-7677 pubmed publisher
  107. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  108. Tian X, Ye M, Cao Y, Wang C. Losartan Improves Palmitate-Induced Insulin Resistance in 3T3-L1 Adipocytes Through Upregulation of Src Phosphorylation. Exp Clin Endocrinol Diabetes. 2017;125:136-140 pubmed publisher
  109. Li C, Luo X, Zhao S, Siu G, Liang Y, Chan H, et al. COPI-TRAPPII activates Rab18 and regulates its lipid droplet association. EMBO J. 2017;36:441-457 pubmed publisher
  110. Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan X, et al. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 2017;8:9251-9266 pubmed publisher
  111. Wymant J, Hiscox S, Westwell A, Urbé S, Clague M, Jones A. The Role of BCA2 in the Endocytic Trafficking of EGFR and Significance as a Prognostic Biomarker in Cancer. J Cancer. 2016;7:2388-2407 pubmed
  112. Kneissl J, Hartmann A, Pfarr N, Erlmeier F, Lorber T, Keller S, et al. Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines. J Cancer Res Clin Oncol. 2017;143:573-600 pubmed publisher
  113. Mukhopadhyay C, Triplett A, Bargar T, HECKMAN C, Wagner K, Naramura M. Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation. Proc Natl Acad Sci U S A. 2016;113:E8228-E8237 pubmed publisher
  114. Lee H, Khan S, Khaliqdina S, Altintas M, Grahammer F, Zhao J, et al. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1. J Biol Chem. 2017;292:732-747 pubmed publisher
  115. Zhang Y, Yang J, Ding M, Li L, Lu Z, Zhang Q, et al. Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC. Oncol Lett. 2016;12:3241-3249 pubmed
  116. Scharaw S, Iskar M, Ori A, Boncompain G, Laketa V, Poser I, et al. The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR. J Cell Biol. 2016;215:543-558 pubmed
  117. Reuther C, Heinzle V, Nölting S, Herterich S, Hahner S, Halilovic E, et al. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. Neuroendocrinology. 2018;106:1-19 pubmed publisher
  118. Amessou M, Ebrahim A, Dilly A, Joseph M, Tabolina M, Chukkapalli S, et al. Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3). Oncotarget. 2016;7:79203-79216 pubmed publisher
  119. Grugan K, Dorn K, Jarantow S, Bushey B, Pardinas J, Laquerre S, et al. Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cells. MAbs. 2017;9:114-126 pubmed publisher
  120. Parrales A, Ranjan A, Iyer S, Padhye S, Weir S, Roy A, et al. DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway. Nat Cell Biol. 2016;18:1233-1243 pubmed publisher
  121. Yong K, Li A, Ou W, Hong C, Zhao W, Wang F, et al. Targeting SALL4 by entinostat in lung cancer. Oncotarget. 2016;7:75425-75440 pubmed publisher
  122. Mitra S, Ghosh B, Gayen N, Roy J, Mandal A. Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation. J Biol Chem. 2016;291:24579-24593 pubmed
  123. Truong D, Puleo J, Llave A, Mouneimne G, Kamm R, Nikkhah M. Breast Cancer Cell Invasion into a Three Dimensional Tumor-Stroma Microenvironment. Sci Rep. 2016;6:34094 pubmed publisher
  124. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  125. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  126. Hang Q, Isaji T, Hou S, Zhou Y, Fukuda T, Gu J. N-Glycosylation of integrin ?5 acts as a switch for EGFR-mediated complex formation of integrin ?5?1 to ?6?4. Sci Rep. 2016;6:33507 pubmed publisher
  127. Edinger N, Lebendiker M, Klein S, Zigler M, Langut Y, Levitzki A. Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF. PLoS ONE. 2016;11:e0162321 pubmed publisher
  128. Xu J, Xiong G, Cao Z, Huang H, Wang T, You L, et al. PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value. J Exp Clin Cancer Res. 2016;35:133 pubmed publisher
  129. Kimani S, Kumar S, Davra V, Chang Y, Kasikara C, Geng K, et al. Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase. Cell Commun Signal. 2016;14:19 pubmed publisher
  130. Mair B, Konopka T, Kerzendorfer C, Sleiman K, Salic S, Serra V, et al. Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity. PLoS Genet. 2016;12:e1006279 pubmed publisher
  131. Jiang M, Qiu J, Zhang L, Lu D, Long M, Chen L, et al. Changes in tension regulates proliferation and migration of fibroblasts by remodeling expression of ECM proteins. Exp Ther Med. 2016;12:1542-1550 pubmed
  132. Li C, Lim S, Xia W, Lee H, Chan L, Kuo C, et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun. 2016;7:12632 pubmed publisher
  133. Jaako K, Waniek A, Parik K, Klimaviciusa L, Aonurm Helm A, Noortoots A, et al. Prolyl endopeptidase is involved in the degradation of neural cell adhesion molecules in vitro. J Cell Sci. 2016;129:3792-3802 pubmed
  134. Sun M, Cai J, Anderson R, Sun Y. Type I ? Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6. J Biol Chem. 2016;291:21461-21473 pubmed
  135. LAW M, Ferreira R, Davis B, Higgins P, Kim J, Castellano R, et al. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Res. 2016;18:80 pubmed publisher
  136. Im J, Yoon S, Kim B, Ban H, Won K, Chung K, et al. DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes ?-catenin-mediated invasion. Biochim Biophys Acta. 2016;1859:1449-1458 pubmed publisher
  137. Carino A, Graziosi L, D Amore C, Cipriani S, Marchianò S, Marino E, et al. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget. 2016;7:61021-61035 pubmed publisher
  138. Zhang Y, Velez Delgado A, Mathew E, Li D, Mendez F, Flannagan K, et al. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124-136 pubmed publisher
  139. Deblois G, Smith H, Tam I, Gravel S, Caron M, Savage P, et al. ERR? mediates metabolic adaptations driving lapatinib resistance in breast cancer. Nat Commun. 2016;7:12156 pubmed publisher
  140. Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed publisher
  141. Huang C, Lee C, Lin H, Chang J. Cathepsin S attenuates endosomal EGFR signalling: A mechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors. Sci Rep. 2016;6:29256 pubmed publisher
  142. Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed publisher
  143. Wang J, Farris A, Xu K, Wang P, Zhang X, Duong D, et al. GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis. Nat Commun. 2016;7:11795 pubmed publisher
  144. Schütz I, López Hernández T, Gao Q, Puchkov D, Jabs S, Nordmeyer D, et al. Lysosomal Dysfunction Caused by Cellular Accumulation of Silica Nanoparticles. J Biol Chem. 2016;291:14170-84 pubmed publisher
  145. Chamberland J, Antonow L, Dias Santos M, Ritter B. NECAP2 controls clathrin coat recruitment to early endosomes for fast endocytic recycling. J Cell Sci. 2016;129:2625-37 pubmed publisher
  146. He F, Wei L, Luo W, Liao Z, Li B, Zhou X, et al. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. Oncotarget. 2016;7:37000-37012 pubmed publisher
  147. Currier M, Lee S, Stobart C, Hotard A, Villenave R, Meng J, et al. EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression. PLoS Pathog. 2016;12:e1005622 pubmed publisher
  148. Rapiteanu R, Davis L, Williamson J, Timms R, Paul Luzio J, Lehner P. A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin. Traffic. 2016;17:940-58 pubmed publisher
  149. Lin S, Choe J, Du P, Triboulet R, Gregory R. The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. Mol Cell. 2016;62:335-345 pubmed publisher
  150. Jahani Asl A, Yin H, Soleimani V, Haque T, Luchman H, Chang N, et al. Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat Neurosci. 2016;19:798-806 pubmed publisher
  151. Hatanaka M, Higashi Y, Kawai K, Su J, Zeng W, Chen X, et al. CD147-targeted siRNA in A375 malignant melanoma cells induces the phosphorylation of EGFR and downregulates cdc25C and MEK phosphorylation. Oncol Lett. 2016;11:2424-2428 pubmed
  152. Jadwin J, Oh D, Curran T, Ogiue Ikeda M, Jia L, White F, et al. Time-resolved multimodal analysis of Src Homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases. elife. 2016;5:e11835 pubmed publisher
  153. Phelps Polirer K, Abt M, Smith D, Yeh E. Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer. PLoS ONE. 2016;11:e0153025 pubmed publisher
  154. Huang M, Liu T, Ma P, Mitteer R, Zhang Z, Kim H, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest. 2016;126:1801-14 pubmed publisher
  155. Mancini M, Lien E, Toker A. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis. Oncotarget. 2016;7:17301-13 pubmed publisher
  156. Wen Y, Li H, Zeng Y, Wen W, Pendleton K, Lui V, et al. MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin. Oncotarget. 2016;7:23300-11 pubmed publisher
  157. Meng Y, Zheng L, Yang Y, Wang H, Dong J, Wang C, et al. A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors. Oncogenesis. 2016;5:e211 pubmed publisher
  158. Ezawa I, Sawai Y, Kawase T, Okabe A, Tsutsumi S, Ichikawa H, et al. Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells. Cancer Sci. 2016;107:734-45 pubmed publisher
  159. Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, et al. Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat Commun. 2016;7:11030 pubmed publisher
  160. Atiq R, Hertz R, Eldad S, Smeir E, Bar Tana J. Suppression of B-Raf(V600E) cancers by MAPK hyper-activation. Oncotarget. 2016;7:18694-704 pubmed publisher
  161. Saygideğer Kont Y, Minas T, Jones H, Hour S, Çelik H, Temel I, et al. Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells. Neoplasia. 2016;18:111-20 pubmed publisher
  162. Haven B, Heilig E, Donham C, Settles M, Vasilevsky N, Owen K. Registered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. elife. 2016;5: pubmed publisher
  163. Kim D, Helfman D. Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling. Oncogene. 2016;35:4495-508 pubmed publisher
  164. Hennig A, Markwart R, Wolff K, Schubert K, Cui Y, Prior I, et al. Feedback activation of neurofibromin terminates growth factor-induced Ras activation. Cell Commun Signal. 2016;14:5 pubmed publisher
  165. Nakazawa M, Eisinger Mathason T, Sadri N, Ochocki J, Gade T, Amin R, et al. Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth. Nat Commun. 2016;7:10539 pubmed publisher
  166. Hayashi H, Al Mamun A, Sakima M, Sato M. Activator of G-protein signaling 8 is involved in VEGF-mediated signal processing during angiogenesis. J Cell Sci. 2016;129:1210-22 pubmed publisher
  167. Derangère V, Fumet J, Boidot R, Bengrine L, Limagne E, Chevriaux A, et al. Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?. Oncotarget. 2016;7:9309-21 pubmed publisher
  168. Theodosiou M, Widmaier M, Böttcher R, Rognoni E, Veelders M, Bharadwaj M, et al. Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin. elife. 2016;5:e10130 pubmed publisher
  169. Evans M, Sauer S, Nath S, Robinson T, Morse M, Devi G. X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity. Cell Death Dis. 2016;7:e2073 pubmed publisher
  170. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE. 2016;11:e0147344 pubmed publisher
  171. Ketel K, Krauss M, Nicot A, Puchkov D, Wieffer M, Müller R, et al. A phosphoinositide conversion mechanism for exit from endosomes. Nature. 2016;529:408-12 pubmed publisher
  172. Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, et al. The LINK-A lncRNA activates normoxic HIF1? signalling in triple-negative breast cancer. Nat Cell Biol. 2016;18:213-24 pubmed publisher
  173. Salova A, Belyaeva T, Leontieva E, Zlobina M, Kharchenko M, Kornilova E. Quantum dots implementation as a label for analysis of early stages of EGF receptor endocytosis: a comparative study on cultured cells. Oncotarget. 2016;7:6029-47 pubmed publisher
  174. Hessmann E, Zhang J, Chen N, Hasselluhn M, Liou G, Storz P, et al. NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation. Stem Cells Int. 2016;2016:5272498 pubmed publisher
  175. Roshan A, Murai K, Fowler J, Simons B, Nikolaidou Neokosmidou V, Jones P. Human keratinocytes have two interconvertible modes of proliferation. Nat Cell Biol. 2016;18:145-56 pubmed publisher
  176. Baumdick M, Brüggemann Y, Schmick M, Xouri G, Sabet O, Davis L, et al. EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling. elife. 2015;4: pubmed publisher
  177. Chen J, Chen Y, Yen C, Chen W, Huang W. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3. Oncotarget. 2016;7:473-89 pubmed publisher
  178. Safavi S, Järnum S, Vannas C, Udhane S, Jonasson E, Tomić T, et al. HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo. Oncotarget. 2016;7:433-45 pubmed publisher
  179. Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke J, et al. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells. Oncogene. 2016;35:3880-6 pubmed publisher
  180. Ponti D, Bastianelli D, Rosa P, Pacini L, Ibrahim M, Rendina E, et al. The expression of B23 and EGR1 proteins is functionally linked in tumor cells under stress conditions. BMC Cell Biol. 2015;16:27 pubmed publisher
  181. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  182. Oprea T, Sklar L, Agola J, Guo Y, Silberberg M, Roxby J, et al. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases. PLoS ONE. 2015;10:e0142182 pubmed publisher
  183. Chen S, Chen Y, Chen B, Cai Y, Zou Z, Wang J, et al. Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway. Evid Based Complement Alternat Med. 2015;2015:645727 pubmed publisher
  184. Majumder P, Chakrabarti O. Mahogunin regulates fusion between amphisomes/MVBs and lysosomes via ubiquitination of TSG101. Cell Death Dis. 2015;6:e1970 pubmed publisher
  185. Nikonova A, Deneka A, Eckman L, Kopp M, Hensley H, Egleston B, et al. Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease. Front Oncol. 2015;5:228 pubmed publisher
  186. Hirano T, Yasuda H, Tani T, Hamamoto J, Oashi A, Ishioka K, et al. In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer. Oncotarget. 2015;6:38789-803 pubmed publisher
  187. Dong Y, Hou W, Li Y, Liu D, Hao G, Zhang H, et al. Unexpected requirement for a binding partner of the syntaxin family in phagocytosis by murine testicular Sertoli cells. Cell Death Differ. 2016;23:787-800 pubmed publisher
  188. Yang C, Lowther K, Lalioti M, Seli E. Embryonic Poly(A)-Binding Protein (EPAB) Is Required for Granulosa Cell EGF Signaling and Cumulus Expansion in Female Mice. Endocrinology. 2016;157:405-16 pubmed publisher
  189. Liu F, Hon G, Villa G, Turner K, Ikegami S, Yang H, et al. EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling. Mol Cell. 2015;60:307-18 pubmed publisher
  190. Kuo H, Hsu H, Chen Y, Chang Y, Liu F, Wu C. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer. Glycobiology. 2016;26:155-65 pubmed publisher
  191. Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, et al. Epigenetic silencing of miR-145-5p contributes to brain metastasis. Oncotarget. 2015;6:35183-201 pubmed publisher
  192. Mehner C, Oberg A, Kalli K, Nassar A, Hockla A, Pendlebury D, et al. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers. Oncotarget. 2015;6:35737-54 pubmed publisher
  193. Cecchetti S, Bortolomai I, Ferri R, Mercurio L, Canevari S, Podo F, et al. Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma. PLoS ONE. 2015;10:e0136120 pubmed publisher
  194. Bollu L, Katreddy R, Blessing A, Pham N, Zheng B, Wu X, et al. Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation. Oncotarget. 2015;6:34992-5003 pubmed publisher
  195. Kitatani K, Usui T, Sriraman S, Toyoshima M, Ishibashi M, Shigeta S, et al. Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid. Oncogene. 2016;35:2801-12 pubmed publisher
  196. Vennin C, Spruyt N, Dahmani F, Julien S, Bertucci F, Finetti P, et al. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget. 2015;6:29209-23 pubmed publisher
  197. Valley C, Arndt Jovin D, Karedla N, Steinkamp M, Chizhik A, Hlavacek W, et al. Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer. Mol Biol Cell. 2015;26:4087-99 pubmed publisher
  198. Wu Y, Deng W, Klinke D. Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst. 2015;140:6631-42 pubmed publisher
  199. Fu Y, Cruz Monserrate Z, Helen Lin H, Chung Y, Ji B, Lin S, et al. Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype. Sci Rep. 2015;5:13347 pubmed publisher
  200. Morancho B, Martínez Barriocanal Ã, Villanueva J, Arribas J. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Res. 2015;17:106 pubmed publisher
  201. Tang Y, Ye M, Du Y, Qiu X, Lv X, Yang W, et al. EGFR signaling upregulates surface expression of the GluN2B-containing NMDA receptor and contributes to long-term potentiation in the hippocampus. Neuroscience. 2015;304:109-21 pubmed publisher
  202. Li W, Qiu Y, Zhang H, Tian X, Fang W. P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway. PLoS ONE. 2015;10:e0133165 pubmed publisher
  203. Lin C, Pan C, Wang C, Liu S, Hsiao L, Yang C. Tumor necrosis factor-alpha induces VCAM-1-mediated inflammation via c-Src-dependent transactivation of EGF receptors in human cardiac fibroblasts. J Biomed Sci. 2015;22:53 pubmed publisher
  204. Yao X, Wu Y, Zhu M, Qian H, Chen Y. Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase. Oncol Lett. 2015;10:479-484 pubmed
  205. Forse C, Agarwal S, Pinnaduwage D, Gertler F, Condeelis J, Lin J, et al. Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer. BMC Cancer. 2015;15:483 pubmed publisher
  206. Yang L, Li Y, Bhattacharya A, Zhang Y. Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant. EBioMedicine. 2015;2:396-405 pubmed
  207. Ma S, Yin N, Qi X, Pfister S, Zhang M, Ma R, et al. Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). Oncotarget. 2015;6:13320-33 pubmed
  208. Min H, Yun H, Lee J, Lee H, Cho J, Jang H, et al. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Mol Cancer. 2015;14:113 pubmed publisher
  209. Chen C, Kim K, Lau L. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation. Oncogene. 2016;35:1314-23 pubmed publisher
  210. Li T, Lu H, Mukherjee D, Lahiri S, Shen C, Yu L, et al. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer. Oncotarget. 2015;6:21428-42 pubmed
  211. Teng Y, Radde B, Litchfield L, Ivanova M, Prough R, Clark B, et al. Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells. J Biol Chem. 2015;290:15799-811 pubmed publisher
  212. Rios Doria J, Sabol D, Chesebrough J, Stewart D, Xu L, Tammali R, et al. A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways. Mol Cancer Ther. 2015;14:1637-49 pubmed publisher
  213. Chien P, Lin C, Hsiao L, Yang C. c-Src/Pyk2/EGFR/PI3K/Akt/CREB-activated pathway contributes to human cardiomyocyte hypertrophy: Role of COX-2 induction. Mol Cell Endocrinol. 2015;409:59-72 pubmed publisher
  214. Ferreira R, Law M, Jahn S, Davis B, Heldermon C, Reinhard M, et al. Novel agents that downregulate EGFR, HER2, and HER3 in parallel. Oncotarget. 2015;6:10445-59 pubmed
  215. Fausther M, Goree J, Lavoie Ã, Graham A, Sévigny J, Dranoff J. Establishment and characterization of rat portal myofibroblast cell lines. PLoS ONE. 2015;10:e0121161 pubmed publisher
  216. Hoekstra E, Kodach L, Das A, Ruela de Sousa R, Ferreira C, Hardwick J, et al. Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer. Oncotarget. 2015;6:8300-12 pubmed
  217. Wang Y, Han A, Chen E, Singh R, Chichester C, Moore R, et al. The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells. Int J Oncol. 2015;46:1924-34 pubmed publisher
  218. Wilson F, Johannessen C, Piccioni F, Tamayo P, Kim J, Van Allen E, et al. A functional landscape of resistance to ALK inhibition in lung cancer. Cancer Cell. 2015;27:397-408 pubmed publisher
  219. Wei Z, Yu D, Bi Y, Cao Y. A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury. Mol Med Rep. 2015;12:63-70 pubmed publisher
  220. Isidro R, Cruz M, Isidro A, Baez A, Arroyo A, González Marqués W, et al. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia. World J Gastroenterol. 2015;21:1749-58 pubmed publisher
  221. Rayavarapu R, Heiden B, Pagani N, Shaw M, Shuff S, Zhang S, et al. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment. J Biol Chem. 2015;290:8722-33 pubmed publisher
  222. Greenall S, Donoghue J, van Sinderen M, Dubljevic V, Budiman S, Devlin M, et al. EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications. Oncogene. 2015;34:5277-87 pubmed publisher
  223. Kozlova N, Samoylenko A, Drobot L, Kietzmann T. Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinog. 2016;55:170-81 pubmed publisher
  224. Fillmore C, Xu C, Desai P, Berry J, Rowbotham S, Lin Y, et al. EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors. Nature. 2015;520:239-42 pubmed publisher
  225. Yoo J, Kim T, Kong S, Lee J, Choi W, Kim K, et al. Role of Mig-6 in hepatic glucose metabolism. J Diabetes. 2016;8:86-97 pubmed publisher
  226. Liu Z, Leng E, Gunasekaran K, Pentony M, Shen M, Howard M, et al. A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism. J Biol Chem. 2015;290:7535-62 pubmed publisher
  227. Maurya S, Mishra J, Abbas S, Bandyopadhyay S. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators. Mol Neurobiol. 2016;53:968-82 pubmed publisher
  228. Pino M, Verstraeten S. Tl(I) and Tl(III) alter the expression of EGF-dependent signals and cyclins required for pheochromocytoma (PC12) cell-cycle resumption and progression. J Appl Toxicol. 2015;35:952-69 pubmed publisher
  229. Kumar S, Das S, Rachagani S, Kaur S, Joshi S, Johansson S, et al. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer. Oncogene. 2015;34:4879-89 pubmed publisher
  230. Smithline Z, Nikonova A, Hensley H, Cai K, Egleston B, Proia D, et al. Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in mice. PLoS ONE. 2014;9:e114403 pubmed publisher
  231. Diesenberg K, Beerbaum M, Fink U, Schmieder P, Krauss M. SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR. J Cell Sci. 2015;128:397-407 pubmed publisher
  232. Peng H, Kaplan N, Yang W, Getsios S, Lavker R. FIH-1 disrupts an LRRK1/EGFR complex to positively regulate keratinocyte migration. Am J Pathol. 2014;184:3262-71 pubmed publisher
  233. Hong Y, Kim J, Pectasides E, Fox C, Hong S, Ma Q, et al. Src mutation induces acquired lapatinib resistance in ERBB2-amplified human gastroesophageal adenocarcinoma models. PLoS ONE. 2014;9:e109440 pubmed publisher
  234. Tan L, Wang J, Tanizaki J, Huang Z, Aref A, Rusan M, et al. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proc Natl Acad Sci U S A. 2014;111:E4869-77 pubmed publisher
  235. Li N, Ramil C, Lim R, Lin Q. A genetically encoded alkyne directs palladium-mediated protein labeling on live mammalian cell surface. ACS Chem Biol. 2015;10:379-84 pubmed publisher
  236. Young O, Tang Z, Niven Fairchild T, Tadesse S, Krikun G, Norwitz E, et al. Toll-like receptor-mediated responses by placental Hofbauer cells (HBCs): a potential pro-inflammatory role for fetal M2 macrophages. Am J Reprod Immunol. 2015;73:22-35 pubmed publisher
  237. Gao X, Yu L, Moore A, Kissling G, Waalkes M, Dixon D. Cadmium and proliferation in human uterine leiomyoma cells: evidence of a role for EGFR/MAPK pathways but not classical estrogen receptor pathways. Environ Health Perspect. 2015;123:331-6 pubmed publisher
  238. Holland W, Chinn D, Lara P, Gandara D, Mack P. Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines. J Cancer Res Clin Oncol. 2015;141:615-26 pubmed publisher
  239. De Santis R, Rosi A, Anastasi A, Chiapparino C, Albertoni C, Leoni B, et al. Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab. Oncotarget. 2014;5:9239-55 pubmed
  240. Hamdollah Zadeh M, Amin E, Hoareau Aveilla C, Domingo E, Symonds K, Ye X, et al. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance. Mol Oncol. 2015;9:167-78 pubmed publisher
  241. Li L, Wu P, Lee J, Li P, Hsieh W, Ho C, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS ONE. 2014;9:e104203 pubmed publisher
  242. Czaplinska D, Turczyk L, Grudowska A, Mieszkowska M, Lipinska A, Skladanowski A, et al. Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration. Biochim Biophys Acta. 2014;1843:2461-70 pubmed publisher
  243. Wang J, Mikse O, Liao R, Li Y, Tan L, Jänne P, et al. Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells. Oncogene. 2015;34:2167-77 pubmed publisher
  244. Tjin Tham Sjin R, Lee K, Walter A, Dubrovskiy A, Sheets M, Martin T, et al. In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing. Mol Cancer Ther. 2014;13:1468-79 pubmed publisher
  245. Zhang L, Castanaro C, Luan B, Yang K, Fan L, Fairhurst J, et al. ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models. Mol Cancer Ther. 2014;13:1345-55 pubmed publisher
  246. Stratmann A, Fecher D, Wangorsch G, Göttlich C, Walles T, Walles H, et al. Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model. Mol Oncol. 2014;8:351-65 pubmed publisher
  247. Gowing G, Shelley B, Staggenborg K, Hurley A, Avalos P, Victoroff J, et al. Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats. Neuroreport. 2014;25:367-72 pubmed publisher
  248. Chen Z, Chen J, Gu Y, Hu C, Li J, Lin S, et al. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells. Oncogene. 2014;33:3869-77 pubmed publisher
  249. Brouxhon S, Kyrkanides S, Teng X, O Banion M, Clarke R, Byers S, et al. Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers. Mol Carcinog. 2014;53:893-906 pubmed publisher
  250. Sigurdsson V, Ingthorsson S, Hilmarsdottir B, Gustafsdottir S, Franzdóttir S, Arason A, et al. Expression and functional role of sprouty-2 in breast morphogenesis. PLoS ONE. 2013;8:e60798 pubmed publisher
  251. Fong G, Backman L, Andersson G, Scott A, Danielson P. Human tenocytes are stimulated to proliferate by acetylcholine through an EGFR signalling pathway. Cell Tissue Res. 2013;351:465-75 pubmed publisher
  252. Yamashita M, Chattopadhyay S, Fensterl V, Saikia P, Wetzel J, Sen G. Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling. Sci Signal. 2012;5:ra50 pubmed publisher
  253. Restivo G, Nguyen B, Dziunycz P, Ristorcelli E, Ryan R, Özuysal Ö, et al. IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. EMBO J. 2011;30:4571-85 pubmed publisher
  254. Lennerz J, Rühle V, Ceppa E, Neuhuber W, Bunnett N, Grady E, et al. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribu. J Comp Neurol. 2008;507:1277-99 pubmed publisher